152 related articles for article (PubMed ID: 3261863)
1. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.
Schmidt EV; Pattengale PK; Weir L; Leder P
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6047-51. PubMed ID: 3261863
[TBL] [Abstract][Full Text] [Related]
2. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
3. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.
Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW
EMBO J; 1989 Mar; 8(3):749-55. PubMed ID: 2785918
[TBL] [Abstract][Full Text] [Related]
4. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
Adams JM; Harris AW; Pinkert CA; Corcoran LM; Alexander WS; Cory S; Palmiter RD; Brinster RL
Nature; 1985 Dec 12-18; 318(6046):533-8. PubMed ID: 3906410
[TBL] [Abstract][Full Text] [Related]
5. Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.
Yukawa K; Kikutani H; Inomoto T; Uehira M; Bin SH; Akagi K; Yamamura K; Kishimoto T
J Exp Med; 1989 Sep; 170(3):711-26. PubMed ID: 2504875
[TBL] [Abstract][Full Text] [Related]
6. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
7. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
Alexander WS; Schrader JW; Adams JM
Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
[TBL] [Abstract][Full Text] [Related]
8. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
Strasser A; Harris AW; Bath ML; Cory S
Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
[TBL] [Abstract][Full Text] [Related]
9. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
Langdon WY; Harris AW; Cory S; Adams JM
Cell; 1986 Oct; 47(1):11-8. PubMed ID: 3093082
[TBL] [Abstract][Full Text] [Related]
10. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
11. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
12. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.
Möröy T; Fisher P; Guidos C; Ma A; Zimmerman K; Tesfaye A; DePinho R; Weissman I; Alt FW
EMBO J; 1990 Nov; 9(11):3659-66. PubMed ID: 2120050
[TBL] [Abstract][Full Text] [Related]
13. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.
Suda Y; Aizawa S; Hirai S; Inoue T; Furuta Y; Suzuki M; Hirohashi S; Ikawa Y
EMBO J; 1987 Dec; 6(13):4055-65. PubMed ID: 2832150
[TBL] [Abstract][Full Text] [Related]
14. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
15. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.
Harris AW; Pinkert CA; Crawford M; Langdon WY; Brinster RL; Adams JM
J Exp Med; 1988 Feb; 167(2):353-71. PubMed ID: 3258007
[TBL] [Abstract][Full Text] [Related]
16. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.
Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW
EMBO J; 1989 Apr; 8(4):1121-8. PubMed ID: 2501083
[TBL] [Abstract][Full Text] [Related]
17. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
18. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
19. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes.
Benvenisty N; Ornitz DM; Bennett GL; Sahagan BG; Kuo A; Cardiff RD; Leder P
Oncogene; 1992 Dec; 7(12):2399-405. PubMed ID: 1461648
[TBL] [Abstract][Full Text] [Related]
20. Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.
Iwamoto T; Pu M; Ito M; Takahashi M; Isobe K; Nagase F; Kawashima K; Ichihara M; Nakashima I
Eur J Immunol; 1991 Aug; 21(8):1809-14. PubMed ID: 1868872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]